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BACKGROUND: Central nervous system (CNS) tuberculosis (TB) can manifest as meningitis, abscess, 
tuberculoma or other manifestations. CNS TB is a rare TB complication, and its diagnosis remains a challenge 
since  it  has  clinical  and  imaging  features  that  resemble  other  diseases.  Antituberculosis treatment  has  a 
significant role in determining a patient’s outcome and prevent complications and mortality. 
 
CASE PRESENTATION: Here, we report a case of CNS TB manifested as tuberculoma in immunocompetent 
patient complicated with spinal arachnoiditis. Despite a treatment delay, the patient still showed clinical 
improvement after proper treatment with a combination of antituberculosis drug and corticosteroid. 
 
CONCLUSION: Central Nervous System Tuberculoma Complicated with Spinal Arachnoiditis in 
Immunocompetent Patient  CNS  tuberculoma is  a  rare  CNS  TB  manifestation, and  its  diagnosis  remain a 
challenge since its clinical symptoms and radiological findings could mimic other cases such as malignancy, 
pyogenic abscess, toxoplasmosis, sarcoidosis, or neurocysticercosis. 
 
 
 
 
 
 
Introduction 
 
 
Tuberculosis (TB) is a disease caused by 
Mycobacterium tuberculosis and can occur in any 
organs of the human body. In the central nervous 
system, TB can manifest as meningitis, abscess, 
tuberculoma or other manifestations. CNS TB is a 
condition with neurological morbidity and mortality and 
still become a major health problem and threat in 
developing countries especially with the pandemic of 
the human immunodeficiency virus (HIV) [1], [2], [3]. 
 
TB Incidence in Asia & Africa developing 
countries range from 110-165 cases/100.000 
populations per year. About 10% of patient with TB 
could have CNS involvement. Factors associated with 
an increased risk of CNS TB are young age, HIV co- 
infection,         alcoholism,         malignancy,         and 
immunosuppressive agents. Extrapulmonary TB 
manifests in about 40% of patients with HIV positive 
[3]. 
 
Mycobacterium tuberculosis enters the human 
body through droplet inhalation, followed by bacteria 
phagocytosis by macrophage, which induces a 
cascade of inflammation, protective immunity, and 
formation of primary complex. In a short term of 
bacteremia, then the M. tuberculosis basil spread 
hematogenously to any organs including meninges or 
by the formation of an isolated granuloma on 
meninges, subpial surface and subependymal of the 
brain  or  spinal  cord  is  known  as  “Rich  foci”  [4]. 
Rupture or growth of this tuberculosis lesion then 
develops into various type of CNS TB [4]. 
 
With such various type of TB manifestation, 
appropriate diagnosis and management are essential 
to achieve favourable outcomes. In this case report, 
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we discuss a case of a non-HIV woman with 2 types 
of CNS TB manifestation; tuberculoma and spinal 
arachnoiditis. 
 
 
 
 
Case Report 
 
 
A 23-year-old female, Balinese from Buleleng 
regency, came to Sanglah Hospital Denpasar with 
headache, nausea and vomiting for One month before 
hospital admission. The symptoms got worse on the 
last two weeks, accompanied by a fluctuating fever, 
dizziness, shaking off both arm when raised, and 
bilateral leg weakness, but she still could walk without 
assistance  and  did  mild  activities.  She  also 
complained a bit of dyspnea with a mild cough. The 
patient had a history of brain tumour (cerebellar mass) 
and had undergone VP shunt insertion followed by 
tumour removal about 1.5 years before, with biopsy 
result considered as granulomatous lesion suspected 
as tuberculoma (Figure 1). After the surgery, she felt 
the symptoms resolved and discontinued the 
medication. On physical examination, there were 
subfebrile fever, cerebellar symptoms (spontaneous 
nystagmus to all directions on both eyes, limb ataxia, 
tremor, loss of physiological reflexes, muscle atrophy 
especially on both legs and hypotonia). 
 
 
 
 
 
 
 
 
 
 
Figure 1: Histopathological result from a cerebellar mass biopsy; 
Large necrotic foci, some surrounded by histiocytes epitheloid cell 
that forms granulomas with compact aggregates and multinucleated 
giant cell Langhans and specific type 
 
 
On laboratory examination, there was normal 
white blood count (10.26 x 10 µ/µL) with neutrophil 
predominance 88.3%, elevated erythrocyte 
sedimentation  rate  (66.4  mm/hour),  hyponatremia 
(127 mmol/L) with positive cerebrospinal fluid  PCR 
TB.  CSF  culture  was  found  negative  for  M. 
tuberculosis Rapid test for HIV result was non- 
reactive. 
 
Head MRI with contrast revealed irregular 
mass  with  enhancement  and  extensive  perifocal 
 
intramuscular injection of streptomycin were given 
immediately. Intravenous dexamethasone injection 
with a dose of 5 mg was given in interval 6 hours and 
was tapered off 1 mg each week. The patient was 
consulted to  the Internal Medicine Department and 
was assessed as pneumonia; she was given 
cefoperazone I gram/12 hours IV and levofloxacin.750 
mg/24 hours IV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Head MRI with contrast; showed irregular mass with 
perifocal oedema on left cerebellum suggestive as residual/residing 
mass 
 
 
On the third day of hospitalisation patient 
complained a worsening of both leg weakness, she 
could  not  lift  them.  She  also  felt  numbness  and 
tingling sensation from both toes to the navel, 
accompanied  by  difficulty  in  micturition  and 
defecation. On rectal touché examination, the 
sphincter ani muscle tone was decreased. 
 
The  patient  underwent  thoracolumbar  MRI 
with contrast and showed diffuse leptomeningeal 
enhancement along cervical, thoracal and lumbar 
spine with enhancement on cauda equina and nerve 
root  on  lumbal  level  suggestive  as  arachnoiditis 
(Figure  3).  Compound Muscle  Action  Potential 
(CMAP) test showed loss of response on bilateral 
peroneus nerve, lengthening of distal latency and 
decreased of amplitude on bilateral tibialis nerve 
especially on the left side and somatosensory evoked 
potential (SSEP) showed lengthening of P37 latency 
th
 
oedema sized 4.23 x 4.24 x 3.51 cm suggestive as 
consistent with spinal cord lesion above 12 thoracal. 
residual/residing mass. Chest x-ray showed 
pneumonia  with  bilateral  hilar  lymphadenopathy 
Figure 2. 
 
Category   I   antituberculosis   regimen   (oral 
isoniazid 300 mg, rifampicin 600 mg, pyrazinamide 
1500  mg  and  ethambutol  750  mg)  also  of  1  g 
On the 19
th 
day of hospitalisation patient’s 
condition  was  improved,  there  was  no  fever, 
cerebellar signs were improved (spontaneous 
nystagmus were diminished, tremor and ataxia were 
gone), the patient could sit down with help and elevate 
her right leg. She could defecate without laxantia and 
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micturate without a catheter. The patient was 
discharged with category I antituberculosis drug and 
continued streptomycin injection at a health facility 
near her residence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Whole spine vertebral MRI T1, T2, TSE; diffuse 
leptomeningeal  enhancement  along  cervical,  the  thoracal  and 
lumbal segment with the enhancement of cauda equine and spinal 
nerve roots 
 
 
After 3-day outpatient care patient came back 
to   the   hospital   with   a   distended  stomach,   leg 
weakness and numbness persist as previous time 
patient was discharged. On plain abdomen and 3 
position abdomen x-ray, there was distention of gaster 
without signs of ileus. The patient was consulted to 
Digestive Surgery Department, and decompression 
was done by insertion of a nasogastric tube (NGT), 
and the antituberculous drug was continued. An 
evaluation of CSF was performed on day 8 of re- 
hospitalisation with result yellow colour, pleocytosis 
(128 cell/  µL)  with monocyte predominance (90%), 
total protein elevation (72,9 mg/dL) and 
hipoglycoracchia (CSF glucose was 14 mg/dL, with 
CSF glucose/serum ratio 0,13). Dexamethasone 10 
mg was administered intrathecally after CSF sample 
collection and was repeated once with a 1-week 
interval. 
 
The patient then was discharged with the 
improvement of the condition; abdominal distention 
was relieved, she could elevate her both legs, sat 
down by herself, numbness and tingling sensation 
were diminished. She continued antituberculosis drug 
medication at the health facility in her hometown. 
 
 
 
 
Discussion 
 
 
CNS TB occurs in about 1% of TB patients, 
especially in young age, immunosuppressed patient, 
malnutrition, alcoholism, and malignancy. Intracranial 
tuberculoma is a rare condition, found in 1% CNS TB 
[5],  [6].  Tuberculoma  can  cause  focal  neurologic 
symptoms without systemic condition, and its 
radiologic finding can mimic malignancy, pyogenic 
abscess, toxoplasmosis, sarcoidosis or 
neurocysticercosis [7], [8], [6]. 
 
Focal brain lesion involves the process of 
hematogenous spread from a primary focus on other 
organs such as the lung. With low cell-mediated 
immunity and significant inoculation size, a tubercle 
focus on brain parenchyma can develop into 
tuberculoma or abscess [4]. Intracranial tuberculoma 
is a rare complication and usually occur in 
immunocompromised patients such as HIV patients 
and its incidence in patients without TB is not clearly 
described [9], [10]. A serial case report by Guo et al., 
[11] reported 11 cases of infratentorial tuberculoma on 
immunocompetent patients and most of the cases did 
not show any evidence of systemic tuberculosis; only 
1  subject  had  pulmonary  TB.  Infratentorial 
tuberculoma risks patient’s life more than 
supratentorial tuberculoma and rarely reported. 
Tuberculoma can occur in any body parts. However, 
adults tend to have supratentorial tuberculoma while 
infratentorial  tuberculoma  occurs  more  in  children 
[11], [12]. The supporting examination for diagnosis, in 
this case, was a positive result of CSF PCR for M. 
tuberculosis. The microbial CSF culture for M. 
tuberculosis was negative. Lack of sensitivity on 
current diagnostic tests for TB still became a problem 
in supporting early diagnosis of TB. Culture is a gold 
standard; however, its sensitivity is not quite high, 
ranging from 25 to 70%. TB diagnosis cannot be 
excluded from a negative microbial test [13]. PCR can 
detect M. tuberculosis weeks before culture in 80-90% 
of patients with TB whose TB already confirmed by 
culture [14]. 
 
Our patient had a complication of spinal 
arachnoiditis, which is considered as a late 
complication of CNS TB and often causes spinal cord 
and spinal nerve root disorder. Spinal arachnoiditis 
can develop into various clinical conditions such as 
radiculomyelitis, spinal tuberculoma, myelitis, 
syringomyelia, vertebral TB or spinal TB abscess. 
There is 3 possible pathomechanisms for TB spinal 
arachnoiditis; by hematogenous spread to meninges 
and  spinal  cord  parenchyma;  gravitation  of 
tuberculous exudates to the lumbosacral area or via 
direct spread from vertebral TB [15]. With a diffuse 
leptomeningeal enhancement along cervical, thoracal 
and lumbal level accompanied by enhancement of 
cauda equina and spinal nerve roots on whole spine 
MRI examination, it is possible that our patient had 
gravitation of infection from infratentorial to meninges 
along  the  spinal  cord  until  the  spinal  nerve  roots. 
After received category I antituberculosis drug with 
adjunction of streptomycin injection, the patient getting 
improved gradually with diminished of cerebellar 
symptoms and relieved symptoms of radiculomyelitis 
(increased of muscle strength, numbness and tingling 
sensation minimised, micturition and defecation 
returned  to  normal).  Immediate  treatment  with  an 
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antituberculosis drug with first-line drug (isoniazid, 
rifampicin, ethambutol, pyrazinamide and 
streptomycin) is important. At the first 2 months of 
intensive phase patient should receive at least 4 
regimens (isoniazid, rifampicin, ethambutol and 
streptomycin or pyrazinamide) followed by a 
maintenance phase with isoniazid and rifampicin for 7- 
10 months [16]. 
 
The patient also received dexamethasone 
injection with a dose of 5 mg every 6 hours, which 
tapered off weekly and 2 times intratechal 
dexamethasone with a 1-week interval. Corticosteroid 
for tuberculoma patient with spinal TB could benefit in 
improvement of neurological outcome despite its 
controversy, especially in HIV patients. The 
recommended dose according to latest study is 
dexamethasone 0,4 mg/kg/day on first week and 
tapered down 0.1 mg/kg every week until dose 0,1 
mg/k/day, continued orally 4 mg/day and was tapered 
down 1 mg/kg each week until stopped [2], [15], [17]. 
Intratechal steroid in TB meningitis (TBM) remains a 
controversy; even some study does not recommend it. 
Steroid decreases meningeal inflammation and 
consequently affect antituberculosis drug penetration. 
According to a study by Ghosh et al., [18] in children 
with TBM, there was no significant difference in the 
outcome between patients who received oral, 
intravenous or intratechal steroid. 
 
In  conclusion,  CNS  tuberculoma  is  a  rare 
CNS TB manifestation, and its diagnosis remain a 
challenge since its clinical symptoms and radiological 
findings could mimic other cases such as malignancy, 
pyogenic abscess, toxoplasmosis, sarcoidosis, or 
neurocysticercosis. Spinal arachnoiditis as a late 
complication of TB infection may occur. Appropriate 
antituberculosis drug medication is important to 
prevent complications and mortality and should be 
highlighted since it requires a lot of drug combination 
and long treatment duration to achieve a favorable 
outcome of the patients. 
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